YOLFTbeta
Profound Medical Corp

Profound Medical Corp

PROF · NASDAQ · Healthcare / Medical Devices

7.42USD-0.02 (-0.27%)

Price History

Full chart

Market Stats

Previous Close7.44
Open7.44
Day Range7.20 – 7.63
52-Week Range4.80 – 8.95
Volume95.85K
Market Cap216.32M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.99
Dividend Yield0.00%
Beta0.50
50-Day Avg6.76
200-Day Avg6.87

About

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Arun Swarup Menawat MBA, Ph.D.
  • Employees162
  • Headquarters2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5, USA
  • Websitehttps://www.profoundmedical.com

Leadership

  • Dr. Arun Swarup Menawat MBA, Ph.D.Chairman of the Board & CEO · b. 1955
  • Dr. Mathieu Burtnyk Ph.D.Chief Technology Officer · b. 1982
  • Mr. Thomas Tamberrino MBAChief Commercial Officer · b. 1980
  • Mr. Richard R. FabianPresident · b. 1967
  • Mr. Stephen KilmerInvestor Relations
  • Mr. Levant TinazSoftware Developer

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---004.90M1.91M4.17M7.30M6.87M6.68M7.20M10.17M16.38M
Growth (%)-------61.04%+118.47%+74.99%-5.90%-2.79%+7.75%+41.23%+61.10%
Cost of Revenue--81.15K118.72K188.38K3.03M1.31M1.78M3.83M3.92M3.66M2.82M3.47M4.79M
Gross Profit---81.15K-119.03K-188.38K1.87M604.82K2.39M3.47M2.95M3.02M4.38M6.70M11.59M
Gross Margin-----38.18%31.66%57.26%47.56%42.95%45.22%60.87%65.89%70.77%
Operating Expense--4.58M11.96M16.05M19.02M15.43M17.29M22.34M33.24M35.15M33.00M38.17M53.57M
Operating Income-2.63M-4.15M-4.66M-12.08M-16.24M-17.15M-14.83M-14.90M-18.86M-30.29M-32.13M-28.62M-31.47M-41.98M
Operating Margin------349.68%-776.04%-357.07%-258.26%-440.72%-480.86%-397.50%-309.57%-256.27%
EBITDA-2.52M-2.99M-6.31M-11.15M-15.56M-16.46M-19.46M-12.53M-19.50M-28.65M-26.60M-26.78M-25.59M-41.41M
EBITDA Margin------335.66%-1018.77%-300.10%-266.92%-416.82%-398.20%-372.01%-251.70%-252.79%
Net Income-9.14M-14.22M-8.20M-11.80M-12.15M-19.10M-15.24M-15.22M-21.62M-30.70M-28.67M-28.57M-26.48M-43.32M
Net Income Margin------389.38%-797.88%-364.69%-296.03%-446.66%-429.11%-396.85%-260.45%-264.44%
R&D3.05M2.78M2.31M3.70M7.43M7.66M7.54M9.40M9.91M15.28M14.69M14.38M16.15M20.96M
R&D as % of Total Revenue-----156.27%394.48%225.13%135.71%222.28%219.88%199.71%158.85%127.94%
Interest Expense--143.01K4.05M615.87K1.07M755.37K1.04M543.00K66.41K167.10K770.00K--
Interest Expense % of Total Revenue-----21.85%39.54%24.87%7.43%0.97%2.50%10.70%--

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.25M2.57M1.47M15.27M17.63M22.17M34.18M29.89M104.60M86.66M64.42M43.96M70.23M192.94M
Total Liabilities18.42M32.52M102.73K5.21M6.59M10.93M14.63M15.60M7.25M6.15M12.42M12.73M9.81M101.95M
Total Equity-16.17M-29.95M1.37M10.06M11.04M11.25M19.55M14.29M97.35M80.51M52.00M31.22M60.42M90.99M
Cash578.37K606.37K1.71M7.58M15.50M8.83M22.53M14.72M83.91M67.06M46.52M26.21M54.91M81.80M
Total Debt-9.15M2.78M5.77M5.90M4.18M11.60M12.98M1.68M1.38M8.23M7.87M5.12M6.45M
Net Debt-8.55M1.07M-3.37M-10.56M-4.74M-13.75M-3.81M-82.24M-65.69M-38.29M-18.35M-49.79M-75.34M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.06M-3.20M-2.88M-4.94M-14.50M-14.85M-13.43M-15.45M-20.57M-22.36M-25.80M-22.61M-23.45M-38.88M
Investing Cash Flow-219.43K-80.42K-61.28K-6.49M8.91M-997.43K-189.00K-192.79K-350.00K-593.00K----246.24K
Financing Cash Flow1.08M3.31M2.74M18.73M15.90M6.12M27.81M6.80M87.43M5.95M7.03M1.76M54.70M41.86M
Capital Expenditure219.43K80.42K61.28K120.35K808.84K369.50K32.00K2.31350.00K593.00K01.960179.08K
Free Cash Flow-3.28M-3.28M-2.94M-5.06M-11.60M-12.18M-13.43M-15.45M-20.92M-22.95M-25.80M-22.61M-23.45M-39.05M
Dividends Paid---00---------
FCF to OCF107.18%102.52%102.13%102.43%79.98%82.01%100.00%100.00%101.70%102.65%100.00%100.00%100.00%100.46%
Dividend Paid to FCF---0.00%0.00%---------

Earnings

Report DateMay 6, 2016Aug 18, 2016Nov 16, 2016Mar 6, 2017May 9, 2017Aug 23, 2017Nov 7, 2017Mar 26, 2018May 10, 2018Aug 14, 2018Nov 8, 2018Mar 7, 2019May 6, 2019Aug 14, 2019Nov 7, 2019Mar 3, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Mar 2, 2021May 12, 2021Aug 4, 2021Nov 4, 2021Mar 3, 2022May 9, 2022Aug 4, 2022Nov 3, 2022Mar 7, 2023May 10, 2023Aug 9, 2023Nov 2, 2023Mar 7, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 5, 2025May 8, 2025Aug 14, 2025Nov 13, 2025Mar 10, 2026May 7, 2026Aug 6, 2026Nov 12, 2026
EPS Estimate-0.07-0.78-0.65-0.07-0.52-0.07-0.56-0.50-0.31-0.29-0.34-0.45-0.33-0.33-0.38-0.49-0.26-0.21-0.24-0.43-0.29-0.30-0.30-0.37-0.43-0.39-0.38-0.36-0.34-0.34-0.32-0.32-0.31-0.28-0.30-0.32-0.28-0.40-0.38-0.30-0.25-0.22-0.23
EPS Actual-0.10-0.70-0.75-0.07-0.51-0.08-0.70-0.60-0.47-0.38-0.38-0.50-0.22-0.38-0.43-0.32-0.18-0.35-0.33-0.49-0.37-0.35-0.29-0.49-0.40-0.28-0.24-0.46-0.32-0.35-0.26-0.42-0.26-0.28-0.38-0.20-0.36-0.52-0.26-0.27-0.190.26-
Surprise-42.86%10.26%-15.38%0.00%1.92%-14.29%-25.00%-20.00%-51.61%-31.03%-11.76%-11.11%33.33%-15.15%-13.16%34.80%30.77%-66.67%-37.50%-13.95%-27.59%-16.67%3.33%-32.43%6.98%28.21%36.84%-27.78%5.88%-2.94%18.75%-31.25%16.13%0.00%-26.67%37.98%-28.57%-30.00%31.58%10.60%24.00%218.18%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap216.32M
Enterprise Value179.75M
Trailing P/E0.00
Forward P/E0.00
Price / Sales11.33
Price / Book4.19
EPS-0.99
Book Value1.36
Revenue (TTM)19.09M
Gross Profit (TTM)13.70M
EBITDA-34.88M
Profit Margin-171.56%
Operating Margin-445.67%
Return on Equity-73.53%
Return on Assets-39.46%
Shares Outstanding36.54M
Shares Float35.50M
Beta0.50
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 5 analystsTarget 11.14
  • Strong Buy
    4
  • Buy
    1

Ownership Breakdown

Institutions
45.01%
Insiders
4.09%
Retail / Other
50.90%

Top Institutional Holders

  • Fidelity International Ltd
    2.34M6.40%
  • Gagnon Securities LLC
    1.96M5.36%
  • Royce & Associates, LP
    1.12M3.06%
  • Timelo Investment Management Inc.
    1.11M3.05%
  • Gagnon Advisors, LLC
    962.19K2.63%
  • Letko, Brosseau & Associates Inc.
    935.73K2.56%
  • Arnhold & S. Bleichroeder Advisers, LLC
    880.41K2.41%
  • Rosalind Advisors, Inc.
    828.12K2.27%
  • Z3 Capital Partners, LLC
    820.94K2.25%
  • Mmcap International Inc. Spc
    745.15K2.04%
  • Ardsley Advisory Partners
    575.00K1.57%
  • Ring Mountain Capital, LLC
    511.92K1.40%
  • Lagoda Investment Management LP
    501.32K1.37%
  • Royal Bank of Canada
    493.06K1.35%
  • PARAGON Assoc & PARAGON Assoc II JV
    276.00K0.76%
  • Dafna Capital Management LLC
    260.36K0.71%

Top Fund Holders

  • Fidelity True North Cl F
    1.99M5.45%
  • Royce Micro-Cap Trust
    742.78K2.03%
  • First Eagle Small Cap Opportunity I
    407.09K1.11%
  • Royce Micro-Cap Invmt
    343.90K0.94%

Stock Splits

  • Oct 16, 20191:10